BMB Reports Papers in Press available online.

Search Papers In Press
This galley proof is being listed electronically before publishing the final manuscript (It's not final version).

 
Downregulation of JMJD2a and LSD1 is involved in CK2 inhibition-mediated cellular senescence through the p53–SUV39h1 pathway
Jeong-Woo Park 1 (Research worker), Young-Seuk Bae 1,* (professor)
1School of Life Sciences, BK21 FOUR KNU Creative BioResearch Group, Kyungpook National University
Abstract
Lysine methylation is one of the most important histone modifications that modulate chromatin structure. In the present study, the roles of the histone lysine demethylases JMJD2a and LSD1 in CK2 downregulation-mediated senescence were investigated. The ectopic expression of JMJD2a and LSD1 suppressed the induction of senescence-associated モ-galactosidase activity and heterochromatin foci formation as well as the reduction of colony-forming and cell migration ability mediated by CK2 knockdown. CK2 downregulation inhibited JMJD2a and LSD1 expression by activating the mammalian target of rapamycin (mTOR)–ribosomal p70 S6 kinase (p70S6K) pathway. In addition, the downregulation of JMJD2a and LSD1 was involved in activating the p53–p21Cip1/WAF1–SUV39h1–trimethylation of the histone H3 Lys9 (H3K9me3) pathway in CK2-downregulated cells. Further, CK2 downregulation-mediated JMJD2a and LSD1 reduction was found to stimulate the dimethylation of Lys370 on p53 (p53K370me2) and nuclear import of SUV39h1. Therefore, this study indicated that CK2 downregulation reduces JMJD2a and LSD1 expression by activating mTOR, resulting in H3K9me3 induction by increasing the p53K370me2-dependent nuclear import of SUV39h1. These results suggest that CK2 is a potential therapeutic target for age‐related diseases.
Abstract, Accepted Manuscript(in press) [Submitted on October 22, 2021, Accepted on December 14, 2021]
  Copyright © KSBMB. All rights reserved. / Powered by INFOrang Co., Ltd